Roots’ unique ag-tech increases yield by 257% in chives pilot

|

Published 27-NOV-2018 11:35 A.M.

|

2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

Ag-tech growth story, Roots Sustainable Agricultural Technologies (ASX:ROO), has released results from a successful pilot on greenhouse-grown chives using its Root Zone Temperature Optimisation (RZTO) cooling technology, showing a 257% increase in yield.

The RZTO system optimises plant physiology for increased growth, health, productivity and quality by stabilising the root zone temperature of the plant in question. It also mitigates against the impact of daily and seasonal temperature changes, helping farmers grow crops more effectively throughout the year.

Importantly, ROO is the only company in the world with commercial two-in-one root zone cooling and heating technology in its arsenal — a distinctive point of difference in the increasingly competitive ag-tech space.

In the pilot, cooled chives plants had an average fresh weight of 268g, compared to an average weight of 75g for the un-cooled control crop — a dramatic increase of over 250%.

On top of that, RZTO technology also extended the growing cycle. The cooled chive plants continued to grow for 55 days, while the control crop virtually stopped growing after four weeks.

RZTO cooling technology increased the average weight of chives by 257% compared to control cropsCooled chives plants (shown in blue) continued growing for 55 days while uncooled plants (orange) virtually stopped growing after 36 days

The pilot was conducted during the Israeli summer from August through to October at ROO’s research site in central Israel. Traditionally a cool climate crop, high temperatures significantly impact chives’ harvest production and crop quality.

Using the hybrid ground source heat exchange (GSHE) version of the RZTO system, the roots of chives crops were cooled to remain relatively stable around 25 degrees, despite air temperatures in the greenhouse frequently topping 36 degrees. In contrast, the roots of control plantings fluctuated between 27 and 31 degrees.

RZTO technology achieved a 6-degree difference between cooled (purple) and uncooled (grey) chives roots

This chives pilot follows on from successful RZTO cooling proof-of-concepts on other crops, including medical cannabis, making for further demonstration of the versatility of ROO’s disruptive tech.

As Roots CEO, Dr Sharon Devir, noted, these results further demonstrate the effectiveness of the company’s proprietary RZTO cooling technology in significantly increasing crop yield, while also extending the growing cycles of plants that typically require cooler climates.

“Our RZTO cooling technology complements our root zone heating systems, providing farmers in areas affected by weather extremes with a two-in-one year-round solution,” Devir said.

“Pilots and proof of concepts are incredibly important in the agri-tech sector and are essential for generating sales in new segments. Results on a variety of crops, environments and growing conditions validate the versatility of our technology and allow us to begin discussions with a broader target market."



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X